A detection panel of novel methylated DNA markers for malignant pleural effusion

作者
Chao-nan Liang,Nan Liu,Qin Zhang,Mingming Deng,Jiangwei Ma,Jingwen Lu,Yan Yin,Jian Wang,Yuan Miao,Bin She,Qingchang Li,Gang Hou
出处
期刊:Frontiers in Oncology [Frontiers Media]
卷期号:12: 967079-967079 被引量:21
标识
DOI:10.3389/fonc.2022.967079
摘要

Background Cytology remains the gold standard for the detection of malignant cells in pleural effusion. However, its sensitivity is limited. The aim of this study was to establish a novel panel of cancer-specific methylated genes for the differential diagnosis of malignant pleural effusion (MPE). Methods A cohort of 100 cancer patients (68 lung cancer, 32 other malignant tumors) and 48 patients with benign disease presenting with pleural effusion was prospectively enrolled. Pleural effusion was evaluated by means of cytopathological investigation and DNA methylation of SHOX2, RASSF1A, SEPTIN9 and HOXA9 in the cellular fraction. DNA methylation in bisulfite-converted DNA was determined using quantitative methylation-specific real-time PCR (MS-PCR). Cytopathological and DNA methylation results were evaluated with regard to the final clinical diagnosis. Results The LungMe® SHOX2 and RASSF1A Assay (Tellgen Corporation, China) has been reported to be highly sensitive and specific for lung cancer using bronchial aspirates. As expected, LungMe® detected metastases of lung cancer (sensitivity: 76.5%) as well as metastases of other malignant tumors (sensitivity: 68.8%). OncoMe, a novel combination of SHOX2, RASSF1A, SEPTIN9 and HOXA9 methylation, led to an additional 11% increase in the detection rate of MPE, resulting in a sensitivity of 85% and a specificity of 96%. Overall, OncoMe showed a higher positive detection rate in SCLC (100%), LUAC (87%), OC (100%), BC (92.9%), GC (80.0%), and MESO (80%) than in LUSC (50%). Cytopathological analyses only detected 23 positive samples, which were all positively measured by both LungMe® and OncoMe. Conclusion OncoMe has potential for use as a biomarker for the detection of MPE, even not limited to lung cancer.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Zx发布了新的文献求助10
1秒前
酷波er的应助被小马采纳,获得10
1秒前
闪闪含巧完成签到,获得积分10
3秒前
在水一方的应助被吉祥如意采纳,获得10
3秒前
3秒前
真实的千柳完成签到,获得积分10
3秒前
pipiheng完成签到,获得积分10
3秒前
谷音给谷音的求助进行了留言
4秒前
4秒前
元吉的应助被Mingjie123采纳,获得10
4秒前
5秒前
7秒前
发了十篇Nature完成签到,获得积分10
8秒前
Tuniverse_发布了新的文献求助10
9秒前
10秒前
喂喂喂发布了新的文献求助10
11秒前
田様的应助被微微采纳,获得10
11秒前
pp完成签到,获得积分10
11秒前
hygogogo完成签到,获得积分20
12秒前
顺利安发布了新的文献求助10
12秒前
科研通AI6.3的应助被Lion采纳,获得30
13秒前
13秒前
科研通AI2S的应助被十七采纳,获得10
14秒前
慕青的应助被愤怒的千易采纳,获得10
14秒前
14秒前
学不会完成签到,获得积分10
14秒前
许俊梁发布了新的文献求助10
14秒前
15秒前
16秒前
阿金发布了新的文献求助10
16秒前
可爱的函函的应助被耍酷思菱采纳,获得10
18秒前
顺利安完成签到,获得积分10
18秒前
丰富的诗蕾完成签到,获得积分20
19秒前
523发布了新的文献求助10
19秒前
20秒前
小蘑菇的应助被笑点低的海冬采纳,获得10
20秒前
852的应助被笑点低的海冬采纳,获得10
20秒前
20秒前
20秒前
大模型的应助被笑点低的海冬采纳,获得10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181892
求助须知:如何正确求助?哪些是违规求助? 9571628
关于积分的说明 21818984
捐赠科研通 7778258
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557720
邀请新用户注册赠送积分活动 2479621